As shown in Figure 4, TP53 status in CLL can be very heterogeneous, as the prevalence of TP53 abnormalities, including 17p deletion and TP53 mutations, varies across the different phases of the disease (26). Here, TP53 is linked to B-cell chronic lymphocytic leukemia.